Ramipron-H 5/12.5 Tablet

Ramipril 5 mg + Hydrochlorothiazide 12.5 mg

Ramipron-H 5/12.5 Tablet — Ramipril 5 mg + Hydrochlorothiazide 12.5 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Ramipril 5 mg + Hydrochlorothiazide 12.5 mg
Dosage Form Tablet
Pack Type Box
Pack Size 10 x 10 (Alu Alu)
MRP ₹ 1150
Therapy Cardiac + Diabetic — ACE inhibitor combination
Storage Store below 25°C.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Ramipron-H 5/12.5 Tablet

Ramipron-H 5/12.5 Tablet contains Ramipril 5 mg + Hydrochlorothiazide 12.5 mg. Ramipril is a long-acting ACE inhibitor with established cardioprotective benefit (HOPE trial — reduced CV death, MI and stroke in high-risk patients).

Indicated for hypertension, heart failure with reduced ejection fraction, post-MI cardioprotection and prevention of cardiovascular events in high-risk patients.

Camrut Healthcare manufactures the Ramipron range under WHO-GMP conditions for PCD pharma franchise across India.

Indications

  • Essential hypertension
  • Heart failure with reduced ejection fraction
  • Post-MI cardioprotection
  • Cardiovascular event prevention in high-risk patients
  • Diabetic nephropathy (renoprotection)

Mechanism of Action

Ramipril is a prodrug hydrolysed to ramiprilat, a potent angiotensin-converting enzyme (ACE) inhibitor. By blocking conversion of angiotensin I to II, it reduces vasoconstriction, aldosterone secretion and sympathetic activation — lowering BP and providing cardio-renal protection (HOPE trial). HCTZ adds thiazide diuretic effect.

Dosage & Administration

['Adults: 1 tablet once daily', 'Start with lower dose and titrate', 'Monitor BP, renal function and potassium', 'Take with or without food']

Side Effects

['Dry cough (common)', 'Hyperkalaemia', 'Angioedema (rare but serious)', 'Hypotension on initiation', 'Renal impairment (in bilateral renal artery stenosis)']

Contraindications & Precautions

['Pregnancy (teratogenic)', 'Breastfeeding', 'History of ACE-inhibitor-induced angioedema', 'Bilateral renal artery stenosis', 'Concurrent aliskiren in diabetics']

Storage

Store below 25°C.

PCD Pharma Franchise & Third-Party Manufacturing
Ramipron-H 5/12.5 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

q

a

q

a

q

a

q

a

q

a

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.